Pharmacy Benefit Managers (PBMs) are the intermediaries between pharmacies, drug manufacturers, and health plans. They control the flow of prescription drug spending in the United States, managing benefits for over 270 million Americans.
What PBMs Do
- Formulary management: Decide which drugs are covered and at what tier
- Claims processing: Adjudicate prescription claims in real time at the point of sale
- Network management: Contract with pharmacies and set reimbursement rates
- Rebate negotiation: Negotiate rebates from drug manufacturers
- Prior authorization: Determine which prescriptions require pre-approval
Major PBMs
The three largest PBMs control approximately 80% of the market:
- CVS Caremark (Aetna)
- Express Scripts (Cigna)
- OptumRx (UnitedHealth Group)
Other significant PBMs include Humana Pharmacy Solutions, MedImpact, and Prime Therapeutics.
PBM Impact on Independent Pharmacies
PBM reimbursement rates directly affect pharmacy profitability. Independent pharmacies often face:
- Below-cost reimbursements: Some PBMs reimburse below the pharmacy's acquisition cost
- DIR fees: Direct and Indirect Remuneration fees clawed back after the point of sale
- Network restrictions: Narrow networks that exclude independent pharmacies
- MAC pricing: Maximum Allowable Cost lists that cap reimbursement for generic drugs
Why PBM Analysis Matters
Regular PBM reimbursement analysis helps pharmacies identify which insurers are paying fairly and which are systematically underpaying. This data drives decisions about network participation, contract negotiations, and formulary management.